NVIDIA Healthcare introduces a suite of AI microservices, including NIM™ models and GPU-accelerated tools, revolutionizing drug discovery and patient care in healthcare enterprises globally.
NVIDIA Healthcare Gen AI
NVIDIA Healthcare has introduced a groundbreaking catalogue of more than two dozen AI microservices aimed at revolutionizing drug discovery, medical technology (MedTech), and digital health.
These microservices, powered by NVIDIA NIM™ AI models and GPU-accelerated workflows, are poised to revolutionize healthcare enterprises globally by leveraging the latest breakthroughs in generative AI. Read Here official Release
The suite includes NVIDIA NIM™ AI models encompassing a wide range of functionalities, including advanced imaging, natural language processing, speech recognition, and digital biology generation and simulation.
The microservices are customizable building blocks equipped with industry-standard APIs, enabling the creation and deployment of cloud-native applications tailored to the specific needs of healthcare professionals.
Also Read: What is NVIDIA Project GR00T for Humanoid Robots and Major Isaac Robotics Platform?
Moreover, NVIDIA’s accelerated software development kits and tools, such as Parabricks®, MONAI, NeMo™, Riva, and Metropolis, are now available as NVIDIA CUDA-X™ microservices. The tools are instrumental in accelerating workflows related to drug discovery, medical imaging, and genomics analysis, driving innovation and efficiency in healthcare operations.
NVIDIA’s partnerships with leading healthcare companies and platforms, including Cadence and Hippocratic AI, underscore the transformative impact of these microservices. The collaborations aim to enhance molecular design capabilities, streamline drug discovery processes, and improve patient-clinician interactions through AI-guided healthcare agents and clinical conversation platforms.
As NVIDIA continues to drive innovation in healthcare AI, with the availability of NVIDIA’s AI microservices, developers, researchers, and practitioners can seamlessly integrate AI into their workflows and applications, facilitating breakthroughs in drug discovery, disease detection, and patient care.
The microservices can be accessed and deployed across various cloud platforms and NVIDIA-certified systems, empowering healthcare organizations to leverage the full power of generative AI to advance medical science and improve patient outcomes.
Also Read: Microsoft and Nvidia Collaborate to Empower Generative AI for Enterprises
This post was last modified on March 22, 2024 11:46 pm
On April 23, 2025, current President Donald J. Trump signed an executive order to advance…
Google is launching The Android Show: I/O Edition, featuring Android ecosystem president Sameer Samat, to…
The top 11 generative AI companies in the world are listed below. These companies have…
Google has integrated Veo 2 video generation into the Gemini app for Advanced subscribers, enabling…
Perplexity's iOS app now makes its conversational AI voice assistant compatible with Apple devices, enabling…
Bhavish Aggarwal is in talks to raise $300 million for his AI company, Krutrim AI…
